Bard1 | Revolutionising the early detection of lung and other cancers INOVIQ Ltd, INOVIQ, (ASX:IIQ) , IIQ, hTERT test,urine cytology testing,EXO-NET®,pan-exosome capture tool, cancer diagnostic, prostate and pancreatic cancers. We are a leading Australian diagnostics company with an innovative portfolio of diagnostic technologies and products. The Company is focused on developing and commercialising diagnostic solutions for healthcare professionals and patients. We commercialised the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET® pan-exosome capture tool for research purposes. Our cancer diagnostic pipeline includes tests in development for ovarian and breast cancers, and research-stage projects for prostate and pancreatic cancers.